INS and nervous system disorder: Reduced systemic inflammation, increased energy expenditure, improved insulin sensitivity, satiety stimulation, mitochondrial function, blood pressure reduction, appetite suppression, and improved cognitive function from a variety of neurologic diseases are all caused by SCFAs [30,31].